English eShop Research Areas Applications Products Knowledge Services Company Homepage Company About Sartorius Stedim Biotech Compliance Compliance Corporate Governance Report pursuant to Article L 225-37 of the French Commercial Code: Pursuant to Article L. 225 - 37 of the French Commercial Code, the Board of Directors uses this report, which covers each fiscal year ended December 31 of each year, to present the conditions of the preparation and organization of the work of the Board of Directors and the internal controlling and control procedures implemented by the company within the Group. Please find below more information on the Corporate Governance Report pursuant to Article L. 225-37 of the French Commercial Code. Downloads Documents The Board of Directors and its Committees PDF | 161.8 KB | February 19, 2021 The Board of Directors and its Committees - Chairman's Report Pursuant to Article L 225-37 PDF | 302.3 KB | February 19, 2021 Remuneration of the Executive Director and Non-executive Members of the Board 2020 PDF | 98.6 KB | February 19, 2021 Independent Auditor's Fees PDF | 37.2 KB | February 19, 2021 More Information Newsroom Learn More Investor Relations Learn More Board of Directors Learn More Sign Up for Newsletter General Information Imprint Disclaimer Terms & Conditions Legal Documents Patents and Trademarks Data Protection Cookie Policy Declaration of Consent Company About Sartorius Career Investor Relations Newsroom Sartorius Blogs Exhibition | Conferences Contact © 2021 Sartorius AG

English eShop Sign in (0 Items) €0.00 Research Areas Applications Products Knowledge Services Company Supervisory Board Homepage Company About Sartorius Supervisory Board Supervisory Board of Sartorius AG The Supervisory Board monitors and advises the Executive Board. The Supervisory Board consists of twelve members; as stipulated by the German codetermination law governing stock corporations, half of the members are made up of shareholders and half of employees’ representatives.

English eShop Sign in (0 Items) €0.00 Research Areas Applications Products Knowledge Services Company Nine-Month Results of Sartorius Stedim Biotech Learn More News & Publications Presentations Regulated Information Share Financial Calendar Shareholders' Meeting Homepage Company Investor Relations Sartorius Stedim Biotech S.A. Sartorius Stedim Biotech S.A. Investor Relations